New therapeutic aspects of inflammatory cardiomyopathy

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F15%3A00061425" target="_blank" >RIV/00159816:_____/15:00061425 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/15:10294746 RIV/00064165:_____/15:10294746
Result on the web
<a href="http://dx.doi.org/10.2174/138161282104141204142244" target="_blank" >http://dx.doi.org/10.2174/138161282104141204142244</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2174/138161282104141204142244" target="_blank" >10.2174/138161282104141204142244</a>

Result language
angličtina
Original language name
New therapeutic aspects of inflammatory cardiomyopathy
Original language description
Inflammatory cardiomyopathy is a term used for left ventricular systolic dysfunction associated with myocarditis. In order to establish definitely the diagnosis, an endomyocardial biopsy (EMB) must be performed. Based on the results of EMB analysis, specific treatment may be added to conventional heart failure therapy. Immunosuppressive therapy in patients with non-viral inflammatory cardiomyopathy has been shown to be effective, and there is also some evidence that antiviral or antimicrobial therapy may be beneficial.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—

Project
<a href="/en/project/ED1.100%2F02%2F0123" target="_blank" >ED1.100/02/0123: St. Anne´s University Hospital Brno - International Clinical Research Center (FNUSA-ICRC)</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)